PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
on 26 Aug 2024
Last Applicant/ Owned by
Milton Park, Abingdon
Oxfordshire
GB
OX144RQ
Serial Number
87322937 filed on 02th Feb 2017
Registration Number
5353768 registered on 12th Dec 2017
Correspondent Address
Melanie Howard
Filing Basis
1. intent to use
Disclaimer
NO DATA
REPLIMUNE
[ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines ] Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] Read More
Classification Information
Class [005]
Pharmaceutical Products
Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of [ infectious, ]oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, namely, [ anti-infectives ] for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, namely, pharmaceuticals for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system ] diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
[ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 87322937
Mark Type
No Service Mark
Attorney Docket Number
No 221834-00009
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Aug 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 26th Aug 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 12th Jun 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 06th Dec 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 12th Dec 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 04th Sep 2020 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 20th Sep 2018 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 10th Sep 2018 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 11th Apr 2018 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| 28th Mar 2018 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |